Priest D G, Bunni M, Sirotnak F M
Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston 29425.
Cancer Res. 1989 Aug 1;49(15):4204-9.
Reduced folate levels and DNA synthesis were examined in L1210 cells in mice after exposure to a wide range of methotrexate doses. A radioenzymatic assay based upon entrapment of tissue 5,10-methylenetetrahydrofolate (CH2FH4), and other reduced folates after cycling to this form, into a stable ternary complex with thymidylate synthase and [3H]-5-fluoro-2'-deoxyuridine 5'-monophosphate was used to estimate reduced folates. DNA synthesis was estimated from incorporation of [3H]-2'-deoxyuridine into DNA. The predominant reduced folate in cells from untreated animals was 10-formyltetrahydrofolate (10-CHOFH4; 3.59 pmol/10(6) cells). The four other reduced folates measured, tetrahydrofolate (FH4), CH2FH4, dihydrofolate (FH2), and 5-methyltetrahydrofolate (5-CH3FH4), were present in nearly equal amounts yielding a total reduced folate level of 6.24 pmol/10(6) cells. When methotrexate was administered s.c. at doses of 1.5, 12, and 400 mg/kg, the level of FH2 increased dramatically and total tetrahydrofolates measured decreased extensively within 1 h. DNA synthesis was completely inhibited during the first 1-2 h after administration of each dose of methotrexate with onset of recovery after 4 and 20 h at 1.5 and 12 mg/kg and not at all after the highest dose. Both FH4 and CH2FH4 were extensively depleted at 12 and 400 mg/kg methotrexate but considerably less depletion of CH2FH4, and none of FH4, was observed at 1.5 mg/kg during a period when DNA synthesis was essentially abolished. The metabolically linked 5-CH3FH4 and 10-CHOFH4 pools were also extensively depleted following treatment with methotrexate. While FH2 levels expanded extensively after drug treatment, the total increase did not account for the extent of depletion of the combined tetrahydrofolate pools. The change in concentration with time of any one folate pool was apparently not sufficient to explain completely the duration of inhibition of DNA synthesis; however, sustained inhibition of DNA synthesis was generally associated with maintenance of an expanded FH2 pool and delay in repletion of the combined tetrahydrofolate pools. Discussion is presented with respect to the impact of these results on changing notions of the mode of action of classical antifolates.
在给小鼠注射一系列不同剂量的甲氨蝶呤后,检测了L1210细胞中叶酸水平降低和DNA合成的情况。采用一种基于将组织中的5,10-亚甲基四氢叶酸(CH2FH4)以及循环转化为此形式后的其他还原型叶酸捕获到与胸苷酸合成酶和[3H]-5-氟-2'-脱氧尿苷5'-单磷酸形成的稳定三元复合物中的放射酶法来估算还原型叶酸。通过[3H]-2'-脱氧尿苷掺入DNA来估算DNA合成。未处理动物细胞中主要的还原型叶酸是10-甲酰四氢叶酸(10-CHOFH4;3.59 pmol/10(6)个细胞)。所检测的其他四种还原型叶酸,四氢叶酸(FH4)、CH2FH4、二氢叶酸(FH2)和5-甲基四氢叶酸(5-CH3FH4),含量几乎相等,还原型叶酸总水平为6.24 pmol/10(6)个细胞。当以1.5、12和400 mg/kg的剂量皮下注射甲氨蝶呤时,FH2水平在1小时内急剧升高,所检测的总四氢叶酸水平大幅下降。在每次注射甲氨蝶呤后的最初1 - 2小时内,DNA合成完全被抑制,在1.5和12 mg/kg剂量时,分别在4小时和20小时后开始恢复,而在最高剂量后则完全没有恢复。在DNA合成基本被抑制的期间,12和400 mg/kg甲氨蝶呤剂量下,FH4和CH2FH4均被大量消耗,但在1.5 mg/kg剂量下,CH2FH4的消耗明显较少,FH4则未被消耗。经甲氨蝶呤处理后,代谢相关的5-CH3FH4和10-CHOFH4库也被大量消耗。虽然药物处理后FH2水平大幅升高,但总增加量并不能解释四氢叶酸库联合消耗的程度。任何一种叶酸库浓度随时间的变化显然不足以完全解释DNA合成抑制的持续时间;然而,DNA合成的持续抑制通常与FH2库的扩大维持以及四氢叶酸库联合补充的延迟有关。文中讨论了这些结果对经典抗叶酸药物作用方式观念转变的影响。